Self emulsifying drug delivery systems;Systèmes auto-émulsionnables et émulsions sèches

S.T.P. Pharma Pratiques

Volumn 15, Issue 3, 2005, Pages 247-254

  Jannin, Vincent ^a   Chambin, Odile ^b  

^a GATTEFOSSÉ SAS   (France)

^b UFR Pharmacie   (France)

Author keywords

Bioavailability; Dry emulsion; Lipid formulation; Self emulsifying drug delivery system; Stability, manufacturing process

Indexed keywords

ALPHA TOCOPHEROL; CAPRYOL; ESTRADIOL; GELUCIRE; GENTAMICIN; HALOFANTRINE; INDOMETACIN; LABRASOL; NIFEDIPINE; PECEOL; PROGESTERONE; PROPANEDIOL DERIVATIVE; SIMVASTATIN; UBIQUINONE; UK 81252; UNCLASSIFIED DRUG;

BIOAVAILABILITY; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MIXTURE; DRUG RESEARCH; EMULSION; LIPOPHILICITY; MICROBIOLOGY; PHYSICAL CHEMISTRY;

EID: 23844442127     PISSN: 11571497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000; 50:179-188.
2. Kommuru TR, Gurley B, Khan MA, Reddy ID. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10:formulation development and bioavailability assessment. Int J Pharm 2001; 212:233-246.
3. Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm 1998; 167:155-164.
4. Kim JY, Ku YS. Enhanced absorption of indomethacin after oral or rectal administration of self-emulsifying system containing indomethacin to rats. Int J Pharm 2000; 194:81-89.
5. Humberstone AJ, Charman WN. Lipid-based vehicles for oral delivery of poorly water soluble drugs. Adv Drug Delivery Rev 1997; 25:103-128.
6. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci 2000; 11 (suppl. 2):S93-S98.
7. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 1995; 12(11):1561-1572.
8. Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Delivery Rev 1997; 25:47-58.
9. Lawrence MJ, Rees CD. Microemulsion-based media as novel drug delivery systems. Adv Drug Delivery Rev 2000; 45:89-121.
10. Norden TP, Siekmann B, Lundquist S, Malmsten M. Physicochemical characterisation of drug-containing phospholipid-stabilised o/w emulsion for intravenous administration. Eur J Pharm Sci 2001; 13:393-401.
11. Newton N, Peterson J, Podczeck F, Clarke A, Booth S. The influence of formulation variables on the properties of pellets contaning a self-emulsifying mixture. J Pharm Sci 2001; 90:987-995.
12. Itoh K, Tozuka Y, Oguchi T, Yamamoto K. Improvement of physicochemical properties of N-4472, part I formulation design by using self-microemulsifying system. Int J Pharm 2002; 238:153-160.
13. Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm 2002; 235:247-265.
14. Amidon CL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12(3):413-420.
15. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & Pharmacotherapy 2004; 58:173-182.
16. Pillay V, Fassihi R. A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug. Pharm Res 1999; 16:333-337.
17. Hülsmann S, Backensfeld T, Keitel S, Bodmeier R. Melt extrusion - an alternative method for enhancing the dissolution rate of 17 β-estradiol hemihydrate. Eur J Pharm Biopharm 2000; 49:237-242.
18. Barker SA, Yap SP, Yuen KH, McCoy CP, Murphy JR, Craig DQM. An investigation into the structure and bioavailability of α-tocopherol dispersions in Gélucire 44/14. J Control Release 2003; 91:477-488.
19. Farah N, Denis J. Gattefossé Holding, editor. Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion. FR patent FR2710535 B1. 1995 Nov 1995.
20. Yüksel N, Karatas A, Özkan Y, Savaser A, Özkan SA, Baykara T. Enhanced bioavailability of piroxicam using Gélucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2003; 56:453-459.
21. Benameur H, Jannin V, Marchaud D. Gattefossé Holding, editor. Composition pharmaceutique à usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal. FR patent FR2827770 A1. 2003 Jan 2003.
22. Kang BK, Lee JS, Chon SK et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004; 274:65-73.
23. Rama Prasad YV, Eaimtrakarn S, Ishida M et al. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs. Int J Pharm 2003; 268:13-21.
24. Chang RK, Shojaei AH. Effect of a lipoidic excipient on the absorption profile of compound UK 81252 in dogs after oral administration. J Pharm Pharmaceut Sci 2004; 7:8-12.
25. Rama Prasad YV, Minamimoto T, Yoshikawa Y et al. In situ intestinal absorption studies on low molecular weight heparin in rats using Labrasol as absorption enhancer. Int J Pharm 2004; 271:225-232.
26. Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C Houin G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 2004; 278:119-131.
27. Subramanian R, Wasan KM. Effect of lipid excipients on in vitro pancreatic lipase activity. Drug Dev Ind Pharm 2003; 29:885-890.
28. Holm P, Mullertz A, Pedersen GP, Kristensen HC. Comparison of the lymphatic transport of Halofantrine administred in disperse systems containing three different unsaturated fatty acid. Pharm Res 2001; 18(9):1299-1304.
29. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004; 21:201-230.
30. Chambin O, Jannin V, Champion D, Chevalier C, Rochat-Gonthier MH, Pourcelot Y. Influence of cryogenic grinding on properties of a self-emulsifying formulation. Int J Pharm 2004; 278:79-89.
31. Gupta MK, Goldman D, Bogner RH, Tseng YC. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm Dev Technol 2001; 6(4):563-572.
32. Seo A, Holm P, Kristensen HG, Schaefer T. The preparation of agglomerates containing solid dispersions of diazepam by melt granulation in a high shear mixer. Int J Pharm 2003; 259:161-171.
33. Damian F, Blaton N, Naesens L et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gélucire 44/14. Eur J Pharm Sci 2000; 10:311-322.
34. Dordunoo SK, Ford JL, Rubinstein MH. Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or Gélucire 44/14 for liquid filing of hard gelatin capsules. Drug Dev Ind Pharm 1991; 17:1685-1713.
35. Farah N, Rollet M. Nouveaux procédés de préparation à partir d'émulsions sèches de formes orales solides à libération modifée et retardée de leurs principes actifs. French Patent 86 02694. 1986 24 Fév.
36. Berthod A, Rollet M, Farah N. Dry adsorbed emulsions: an oral sustained drug delivery system. J Pharm Sci 1988; 77:216-221.
37. Chambin O, Bellone C, Champion D, Rochat-Gonthier MH, Pourcelot Y. Dry adsorbed emulsion: 1. Characterization of an intricate physicochemical structure. J Pharm Sci 2000; 89:991-999.
38. Chambin O, Bérard V, Rochat-Gonthier MH, Pourcelot Y. Dry adsorbed emulsions. Dissolution behaviour of an intricate formulation. Int J Pharm 2002; 235:169-178.
39. Corveleyn S, Remon JP. Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs. Int J Pharm 1998; 166:6574.
40. Pedersen GP, Fäldt P, Bergenstahl B, Kristensen HG. Solid state characterisation of a dry emulsion: a potential drug delivery system. Int J Pharm 1998; 171:257-270.
41. Dollo G, Le Corre P, Guérin A, Chevanne F, Burgot JL, Leverge R. Spray-dried redispersible oil-in-water emulsion to improve oral bioavail ability of poorly soluble drugs. Eur J Pharm Sci 2003; 19:273-280.
42. Christensen KL, Pedersen GP, Kristensen HG. Preparation of redispersible dry emulsions by spray drying. Int J Pharm 2001; 212:187-194.
43. Hansen T, Holm P, Schultz K. Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid. Int J Pharm 2004; 287:55-66.
44. Christensen KL, Pedersen GP, Kristensen HG. Technical optimisation of redispersible dry emulsions. Int J Pharm 2001; 212:195-202.